CLINICAL_TRIALS
trial_result
· 2022-11-10
Clinical Trial Update: A Pilot Study of the Effects of Botulinum Toxin in the Treatment of Provoked Vestibulodynia [Phase 3]
Summary
Phase 3 pilot trial evaluating botulinum toxin for provoked vestibulodynia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Vestibulodynia | Phase 3 | Status: COMPLETED